Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$556K Sell
12,672
-9,360
-42% -$396K 0.01% 291
2021
Q2
$967K Buy
+22,032
New +$1.03M 0.02% 218
2017
Q2
Sell
-5,596
Closed -$230K 307
2017
Q1
$230K Sell
5,596
-9,057
-62% -$378K 0.02% 268
2016
Q4
$602K Buy
+14,653
New +$539K 0.05% 139
2015
Q1
Sell
-7,761
Closed -$210K 257
2014
Q4
$210K Buy
+7,761
New +$196K 0.02% 221
2014
Q2
Sell
-35,060
Closed -$832K 209
2014
Q1
$832K Buy
35,060
+32,977
+1,583% +$802K 0.11% 85
2013
Q4
$52K Hold
2,083
0.01% 187
2013
Q3
$48K Hold
2,083
0.01% 115
2013
Q2
$43K Buy
+2,083
New +$39.5K 0.01% 146

Other funds holding SNV

Homrich & Berg's SNV Position: Q3 2021 in Review

Homrich & Berg reduced its Synovus (SNV) stake by 42% in Q3 2021, selling an estimated $396K and leaving 12,672 shares worth $556K. The position accounts for 0.01% of the portfolio, ranked #291.

Homrich & Berg first reported a position in SNV in Q2 2013 and has held it in 9 quarters since. The position peaked at $967K in Q2 2021. 386 funds tracked by Wall St. Rank hold SNV as of Q3 2021.

  • Homrich & Berg held 12,672 shares of Synovus worth $556K as of Q3 2021.
  • Homrich & Berg sold 9,360 Synovus shares in Q3 2021, an estimated $396K.
  • Synovus made up 0.01% of Homrich & Berg's portfolio in Q3 2021, its #291 holding.
  • Homrich & Berg first reported a position in Synovus in Q2 2013 and has held it in 9 quarters since.
  • Homrich & Berg's Synovus position peaked at $967K in Q2 2021.
  • 386 funds tracked by Wall St. Rank held Synovus as of Q3 2021.

Based on Homrich & Berg's 13F filing for Q3 2021, filed 8 Dec 2021.